Projects

Identification of risk factors of developing agitation among patients with traumatic brain injury during rehabilitation.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2027

Project Lead

Authors

Dr. Anindya Debnath, Dr. Badarinath Athani, Dr. Jaya Das, Dr. Ijaz N Pillai, Dr. Aneeta Shaji, Dr. Adarsh SS

Project Status

ongoing

Project Type

Prospective observational study